Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $631.9800 (0%) ($620.0600 - $636.1400) on Fri. Jul. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.56% (three month average) | RSI | 58 | Latest Price | $631.9800(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(40%) IVW(38%) IWF(37%) | Factors Impacting REGN price | REGN will decline at least -1.28% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) IYT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.28% (StdDev 2.56%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $633.35 | 5 Day Moving Average | $632.73(-0.12%) | 10 Day Moving Average | $633.34(-0.21%) | 20 Day Moving Average | $633.35(-0.22%) | To recent high | -3.9% | To recent low | 20.1% | Market Cap | $67.008b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |